Nutrition, insulin, IGF-1 metabolism and cancer risk: A summary of epidemiological evidence

Novartis Foundation Symposium

Volumn 262, Issue , 2004, Pages 247-264

  Kaaks, Rudolf ^a   Lonning, ^b   Laron, ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ANIMAL; HUMAN; METABOLISM; NEOPLASM; NUTRITION; REVIEW; RISK FACTOR;

ANIMALS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; NUTRITION PHYSIOLOGY; RISK FACTORS;

EID: 16544366164     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (124)

1. Abate N 1996 Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care 19:292-294
2. Allen N, Appleby P, Davey G, Kaaks R, Rinald S, Key TJ 2002 The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 11:1441-1448
3. Allen N, Appleby P, Kaaks R et al 2003 Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65-74
4. Argente J, Caballo N, Barrios V et al 1997 Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Endocrinol Metab 82:2084-2092
5. Baumann G, Mercado M 1993 Growth hormone-binding proteins in plasma. Nutrition 9:546-553
6. Baxter R, Bryson J, Turtle J 1981 The effect of fasting on liver receptors for prolactin and growth hormone. Metabolism 30:1086-1090
7. Benito M, Valverde A, Lorenzo M 1996 IGF-I: a mitogen also involved in differentiation processes in mammalian cells. Int J Biochem Cell Biol 28:499-510
8. Bereket A, Lang C, Wilson T 1999 Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 31:172-181
9. Bereket A, Lang C, Blethen S et al 1995 Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:1312-1317
10. Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C 1999 Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand 165:51-56
11. Bernardi F, Petraglia F, Seppala M et al 1998 Somatotropic axis and body weight in premenopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. Hum Reprod 13:279-284
12. Bohlke K, Cramer D, Trichopoulos D, Mantzoros C 1998 Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-573
13. Boni-Schnetzler M, Schmid C, Mary J et al 1990 Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 4:1320-1326
14. Bruning P, Bonfrer J, van Noord P et al 1992 Insulin resistance and breast-cancer risk. Int J Cancer 52:511-516
15. Bruning P, Van Doorn J, Bonfrer J et al 1995 Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62:266-270
16. Cancer incidence in five continents 2002 In: Cancer incidence in five continents. IARC Sci Publ, p 1-781
17. Cats A, Dullaart R, Kleibeuker J et al 1996 Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56:523-526
18. Chan J, Stampfer M, Ma J et al 2002 Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94:1099-1106
19. Chan J, Stampfer M, Giovannucci E et al 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
20. Clemmons D, Underwood L 1991 Nutritional regulation of IGF-I and IGF binding proteins. Annu Rev Nutr 11:393-412
21. Cocca C, Gutierrez A, Nunez M et al 2003 Suppression of mammary gland tumorigenesis in diabetic rats. Cancer Detect Prev 27:37-46
22. Cocca C, Martin G, Rivera E et al 1998 An experimental model of diabetes and cancer in rats. Eur J Cancer 34:889-894
23. Colao A, Balzano A, Ferone D et al 1997 Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) 47:23-28
24. Copeland K, Colletti R, Devlin J, McAuliffe T 1990 The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 39:584-587
25. Cordido F, Casanueva F, Vidal J, Dieguez C 1991 Study of insulin-like growth factor I in human obesity. Horm Res 36:187-191
26. Coughlin S, Neaton J, Randall B, Sengupta A 1997 Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer 79:2171-2177
27. Counts D, Gwirtsman H, Carlsson L, Lesem M, Cutler GJ 1992 The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 75:762-767
28. DeFronzo R 1988 Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
29. Del Giudice M, Fantus I, Ezzat S et al 1998 Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120
30. Dickson R, Stancel G 2000 Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr (27):135-145
31. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
32. Dunger D, Cheetham T 1996 Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus. Horm Res 46:2-6
33. Ehrmann D, Barnes R, Rosenfield R 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
34. Elias A, Pandian M, Wang L et al 2000 Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise. Psychoneuroendocrinology 25:453-461
35. Estivariz C, Ziegler T 1997 Nutrition and the insulin-like growth factor system. Endocrine 7:65-71
36. Everhart J, Wright D 1995 Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. J Am Med Assoc 273:1605-1609
37. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen C, Orskov H 1995 Free insulin-like growth factors in human obesity. Metabolism 44(suppl 10):37-44
38. Giovannucci E 1995 Insulin and colon cancer. Cancer Causes Control 6:164-179
39. Giovannucci E, Pollak M, Liu Y et al 2003 Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12:84-89
40. Giovannucci E, Pollak M, Platz E et al 2000 A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9:345-349
41. Goodyear L, Kahn B 1998 Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49:235-261
42. Grimm J 1999 Interaction of physical activity and diet: implications for insulin-glucose dynamics. Public Health Nutr 2:363-368
43. Grundy S, Brewer HJ, JI C et al 2004 Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438
44. Hankinson S, Willett W, Colditz G et al 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
45. Hargreaves M, McKenna M, Jenkins D et al 1998 Muscle metabolites and performance during high-intensity, intermittent exercise. J Appl Physiol 84:1687-1691
46. Harman S, Metter E, Blackman M et al 2000 Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85:4258-4265
47. Henderson B, Ross R, Pike M, Casagrande J 1982 Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232-3239
48. Henriksen E 2002 Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93:788-796
49. Heuson J, Legros N 1970 Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo. Eur J Cancer 6:349-351
50. Heuson J, Legros N 1972 Influence of insulin deprivation on growth of the 7,12-dimethyl-benz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res 32:226-232
51. Hirose K, Toyama T, Iwata H et al 2003 Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239-246
52. Holmes M, Pollak M, Hankinson S 2002 Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations 11:862-867
53. Hotamisligil G 2000 Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 24(suppl 4):S23-S27
54. Houmard J, Shaw C, Hickey M, Tanner C 1999 Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am J Physiol 277:E1055-1060
55. Hu FB, Manson JE, Liu S et al 1999 Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 81:542-547
56. Ish-Shalom D, Christoffersen C, Vorwerk P et al 1997 Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40(suppl 2): S25-S31
57. IARC Handbooks of Cancer Prevention. Vol 6: Weight control and physical activity. IARC press, France
58. Jones J, Clemmons D 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
59. Kaaks R 1996 Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605-625
60. Kaaks R, Toniolo P, Akhmedkhanov A et al 2000a Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592-1600
61. Kaaks R, Lukanova A, Sommersberg B 2000b Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3:157-172
62. Kaaks R, Lukanova A, Kurzer M 2002a Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-1543
63. Kaaks R, Lundin E, Rinaldi S et al 2002b Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13:307-316
64. Kahn B, Flier J 2000 Obesity and insulin resistance. J Clin Invest 106:473-481
65. Keinan-Boker L, Bueno De Mesquita H, Kaaks R et al 2003 Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106:90-95
66. Key T, Pike M 1988 The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205-212
67. Khandwala H, McCutcheon I, Flyvbjerg A, Friend K 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244
68. Koistinen H, Koistinen R, Selenius L, Ylikorkala Q, Seppala M 1996 Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J Appl Physiol 80:760-764
69. Kraegen E, Cooney G, Ye J, Thompson A 2001 Triglycerides, fatty acids and insulin resistance - hyperinsulinemia. Exp Clin Endocrinol Diabetes 109:5516-5526
70. Kritchevsky D 1999 Caloric restriction and experimental carcinogenesis. Toxicol Sci 52(suppl 2):13-16
71. Lawlor M, Alessi D 2001 PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114:2903-2910
72. Le Roith D, Bondy C, Yakar S, Liu J, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
73. LeRoith D 2000 Insulin-like growth factor I receptor signaling - overlapping or redundant pathways? Endocrinology 141:1287-1288
74. LeRoith D, Roberts CJ 2003 The insulin-like growth factor system and cancer. Cancer Lett 195:127-137
75. Li B, Khosravi M, Berkel H et al 2001 Free insulin-like growth factor-I and breast cancer risk. Int J Cancer 91:736-739
76. Lindblad P, Chow W, Chan J et al 1999 The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42:107-112
77. Lukanova A, Soderberg S, Stattin P et al 2002 Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13:509-516
78. Lukanova A, Zeleniuch-Jacquotte A, Lundin E et al 2004 Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262-268
79. Ma J, Pollak M, Giovannucci E et al 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
80. Ma J, Giovannucci E, Pollak M et al 2004 A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96:546-553
81. Mantzoros C, Tzonou A, Signorello L et al 1997 Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76:1115-1118
82. Marin P, Kvist H, Lindstedt G, Sjostrom L, Bjorntorp P 1993 Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes Relat Metab Disord 17:83-89
83. McKeown-Eyssen G 1994 Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3:687-695
84. Mercado M, Baumann G 1995 Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. Arch Med Res 26:101-109
85. Murphy L, Ghahary A 1990 Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11:443-453
86. Muti P, Quattrin T, Grant B et al 2002 Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11:1361-1368
87. Nam S, Lee E, Kim K et al 1997 Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21:355-359
88. Ng E, Ji C, Tan P et al 1998 Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients. Ann Surg Oncol 5:194-201
89. Noguchi T 2000 Protein nutrition and insulin-like growth factor system. Br J Nutr 84(suppl 2):S241-S244
90. Nyomba B, Berard L, Murphy L 1997 Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82:2177-2181
91. Palmqvist R, Hallmans G, Rinaldi S et al 2002 Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50:642-646
92. Pan D, Lillioja S, Kriketos A et al 1997 Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988
93. Perseghin G, Price T, Petersen K et al 1996 Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335:1357-1362
94. Petridou E, Papadiamantis Y, Markopoulos C et al 2000 Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11:383-388
95. Peyrat J, Bonneterre J, Hecquet B et al 1993 Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492-497
96. Prelevic G, Wurzburger M, Balint-Peric L, Ginsburg J 1992 Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm Res 37:125-131
97. Probst-Hensch N, Yuan J, Stanczyk F et al 2001 IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 85:1695-1699
98. Proud C 2004 mTOR-mediated regulation of translation factors by amino acids. Biochem Biophys Res Commun 313:429-436
99. Randle P 1998 Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14:263-283
100. Reaven G 1988 Banting Lecture 1988. Role of insulin resistance in human disease. Nutrition 13:65-66
101. Rutanen E 1998 Insulin-like growth factors in endometrial function. Gynecol Endocrinol 12:399-406
102. Schairer C, Hill D, Sturgeon S et al 2004 Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 108:773-779
103. Schoen R, Tangen C, Kuller L et al 1999 Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 91:1147-1154
104. Shafie S, Grantham F 1981 Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst Monogr 67:51-56
105. Shafie S, Hilf R 1981 Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Cancer Res 41:826-829
106. Stattin P, Bylund A, Rinaldi S et al 2000 Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92:1910-1917
107. Stattin P, Rinaldi S, Biessy C, Hallmans G, Kaaks R 2004 High levels of circulating insulin-like growth factor-I increase prostate cancer risk. A prospective study. J Clin Oncol, in press
108. Steppan C, Lazar M 2002 Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23
109. Stewart C, Rotwein P 1996 Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026
110. Stoll B 1999 Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 53:83-87
111. Storlien L, Tapsell L, Fraser A et al 2001 Insulin resistance. Influence of diet and physical activity. World Rev Nutr Diet 90:26-43
112. Straus D 1994 Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J 8:6-12
113. Suikkari A, Koivisto V, Rutanen E et al 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272
114. Thissen J, Ketelslegers J, Underwood L 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101
115. Tollet P, Enberg B, Mode A 1990 Growth hormone (GH) regulation of cytochrome P-450IIC12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: a hormonal interplay with insulin, IGF-I, and thyroid hormone. Mol Endocrinol 4:1934-1942
116. Toniolo P, Bruning P, Akhmedkhanov A et al 2000 Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828-832
117. Trayhurn P, Beattie J 2001 Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329-339
118. Troisi R, Potischman N, Hoover R, Siiteri P, Brinton L 1997 Insulin and endometrial cancer. Am J Epidemiol 146:476-482
119. Veldhuis J, Liem A, South S et al 1995 Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222
120. Weiderpass E, Partanen T, Kaaks R et al 1998 Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health 24:165-174
121. Werner H, LeRoith D 1996 The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68:183-223
122. Wetterau L, Moore M, Lee K, Shim M, Cohen P 1999 Novel aspects of the insulin-like growth factor binding proteins. Mol Genet Metab 68:161-181
123. Wideroff L, Gridley G, Mellemkjaer L et al 1997 Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365
124. Wolk A, Mantzoros C, Andersson S et al 1998 Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90:911-915